Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Inozyme Pharma, Inc. | Interim CFO | Stock option (Right to Buy) | 15K | May 17, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SPRO | Spero Therapeutics, Inc. | Jul 15, 2023 | 0 | $0 | 3 | Jul 24, 2023 | Interim Chief Financial Officer Exhibit 24.1 - Power of Attorney |
INZY | Inozyme Pharma, Inc. | May 17, 2021 | 1 | $0 | 4 | May 18, 2021 | Interim CFO |
INZY | Inozyme Pharma, Inc. | May 17, 2021 | 0 | $0 | 3 | May 18, 2021 | Interim CFO |